Novel Surgical Approaches to High-Grade Gliomas

Abstract

Treatment of patients with high-grade glioma (HGG) should begin with thorough evaluation by a specialized multidisciplinary team to determine whether or not the patient is appropriate for surgery, chemotherapy and radiotherapy. Particular attention should be paid to the performance status and neurological function. Surgery is the first step in therapeutic intervention. Patients undergo either biopsy, debulking surgery or maximal resection depending on the anatomical location of the tumour and the patient's clinical condition. Extent of resection has a prognostic value. In patients who are 'fit for surgery', the aim is to remove all contrast-enhancing tumour without causing neurological deficit. If microsurgical resection is not feasible, then a biopsy, either open or stereotactic, should be performed to confirm high-grade glioma diagnosis and to perform molecular genetic analyses (MGMT methylation status, loss of heterozygosity in 1p/19q, IDH1 status) as this has treatment implications. Over the past decade, much glioma research has focussed on novel surgical approaches to improve long-term outcomes. The evidence to support the benefit of maximizing extent of resection is growing. Advances in neurosurgical techniques allow safer, more aggressive surgery to maximize tumour resection whilst minimizing neurological deficit. Surgical adjuncts including advanced neuronavigation, intraoperative magnetic resonance imaging, high-frequency ultrasonography, fluorescence-guided microsurgery using intraoperative fluorescence, functional mapping of motor and language pathways, and locally delivered therapies are extending the armamentarium of the neurosurgeon to provide patients with the best outcome. Operating on elderly patients and those with recurrent disease, although controversial, is becoming more common due to emerging neurosurgical approaches. Here, we discuss the emerging surgical techniques and comment on the future of HGG surgery.

Update on Brain Tumors: New Developments in Neuro‐oncologic Diagnosis and Treatment, and Impact on Rehabilitation Strategies

“…De Witt Hamer et al found that surgeries incorporating intraoperative stimulation monitoring had 2 times fewer late severe neurologic deficits (muscle strength <3, aphasia, severe dysphagia, hemianopsia, vegetative state) [35]. Intraoperative ultrasound can also be used in low‐grade gliomas for real‐time imaging, which allows immediate feedback regarding tumor location during surgery; use in high‐grade gliomas is limited due to edema and hemorrhage [36,37].…”

Extract of Herba Anthrisci cerefolii: Chemical Profiling and Insights into Its Anti-Glioblastoma and Antimicrobial Mechanism of Actions

“…Existing therapeutic strategies for GBM include surgery, radiation and chemotherapy. Combined radiotherapy and chemotherapy are currently used for the cytoreduction of the tumor, but over 90% of patients usually experience rapid tumor recurrence [ 4 , 5 , 6 ]. Tumor recurrence, poor prognosis, and the side effects of radio- and chemotherapy suggest the need to prioritize the further search for novel therapeutic approaches, especially among natural sources.…”

The effect of marital status on glioma patient survival: analysis of 617 cases

“…However, overall prognosis remains nonideal. [5,6] For a long time, we have often emphasized that glioma patients should have reasonable medical treatment as biological entities, while ignoring their status as social beings. Socioeconomic status and psychological support also play important roles in their survival prognosis.…”